Who we are
Our Culture
Milestones
Management
Team Capability
Production base
Offices
Cooperation
OMNI Pharma held the launch ceremony of the new inhalation preparation industrialization project
NMPA approves shifeichang in patients with reversible airway obstruction
Omni Pharma completed the D round of hundreds of millions RMB financing, led by Shanghai Healthcare Capital
OMNI Pharma announces the merger with Shanghai SMC Biotechnology Co., Ltd. to accelerate the pace of commercialization
About
Technical
备案号:沪ICP备12031398号-1